Company page

Dyadic International, Inc.

Dyadic International, Inc. (ticker: DYAI) is a public company based in the United States with a market capitalization of approximately $24.9 million. The company focuses on biopharmaceutical development and offers innovative solutions for the production of biologics. Dyadic aims to enhance the efficiency and cost-effectiveness of biopharmaceutical manufacturing processes.